The FDA has approved a subcutaneous formulation of lecanemab (Leqembi Iqlik, Eisai/Biogen) for maintenance dosing in patients with Alzheimer’s disease (AD) with mild cognitive impairment (MCI) or mild ...
For much of the 1990s, old-school MTV viewers heard one of thrash metal's most iconic riffs nearly every hour — the opening bassline to Megadeth's "Peace Sells." The snippet played at the close of ...
New York City became the first city in the country to allow supervised drug use sites where people can use illegal drugs without threat of arrest, under the watch of trained staff, Mayor Bill de ...
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial ...
STOCKHOLM, Aug. 29, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA-B) partner Eisai announced today the U.S. Food and Drug Administration (FDA) has approved the Biologics License ...
Ozempic is approved by the Food and Drug Administration (FDA) for certain uses in people with type 2 diabetes. It can be prescribed off-label to help with weight loss, but it’s not approved for this ...
Rafael Sepulveda Acosta, M.D. Sleep Medicine / Obesity Medicine / Internal Medicine Dr. Rafael Sepulveda Acosta is a board-certified physician with experience in internal medicine, pediatric and adult ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback